Prophylactic Dextrose Gel Does Not Prevent Neonatal Hypoglycemia: A Quasi-Experimental Pilot Study

Area of Science:

• Neonatal Medicine
• Endocrinology
• Pediatrics

Background:

• Neonatal hypoglycemia is a common concern in at-risk newborns.
• Early intervention strategies aim to stabilize blood glucose levels and prevent adverse outcomes.
• Dextrose gel is a potential prophylactic treatment for neonatal hypoglycemia.

Purpose of the Study:

• To evaluate the efficacy of prophylactic dextrose gel in increasing initial blood glucose concentrations.
• To determine if dextrose gel reduces neonatal intensive care unit (NICU) admissions for asymptomatic neonatal hypoglycemia.
• To compare outcomes between at-risk newborns receiving dextrose gel and those receiving standard feeding alone.

Main Methods:

• A quasi-experimental study design was employed.
• At-risk newborns (late preterm, low/high birth weight, infants of diabetic mothers) were allocated to receive prophylactic dextrose gel or serve as controls.
• Blood glucose concentrations were measured 30 minutes post-feeding, and NICU admission rates were compared between groups.

Main Results:

• No significant difference in initial blood glucose concentrations was observed between the dextrose gel group and the control group (P=.69).
• Rates of NICU admission for hypoglycemia treatment were not significantly reduced in the prophylactic group (9.7%) compared to controls (14.6%) (P=.40).
• Multivariable analysis adjusting for covariates also showed no significant difference in glucose concentrations.

Conclusions:

• Prophylactic dextrose gel did not demonstrate efficacy in preventing transient neonatal hypoglycemia or reducing NICU admissions.
• The high carbohydrate concentration of the gel might trigger a hyperinsulinemic response, counteracting its intended effect.
• Exogenous enteral dextrose may have minimal impact on glucose homeostasis in the early hours of life due to active counter-regulatory mechanisms.